Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
SPINT2 is hypermethylated in both IDH1 mutated and wild-type glioblastomas, and exerts tumor suppression via reduction of c-Met activation.
Journal: Journal of neuro-oncology
Published: August 29, 2018
Tumor-suppressive miR148a is silenced by CpG island hypermethylation in IDH1-mutant gliomas.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 17, 2014
Deferred use of bevacizumab for recurrent glioblastoma is not associated with diminished efficacy.
Journal: Neuro-oncology
Published: March 15, 2014
Combined analysis of O6-methylguanine-DNA methyltransferase protein expression and promoter methylation provides optimized prognostication of glioblastoma outcome.
Journal: Neuro-oncology
Published: January 19, 2013
Identification of retinol binding protein 1 promoter hypermethylation in isocitrate dehydrogenase 1 and 2 mutant gliomas.
Journal: Journal of the National Cancer Institute
Published: September 05, 2012
Showing 1-6 of 6
Last Updated: 09/26/2026